Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sonnet BioTherapeutics Holdings, Inc. - Common Stock
(NQ:
SONN
)
1.590
+0.050 (+3.25%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sonnet BioTherapeutics Holdings, Inc. - Common Stock
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Why Cassava Sciences Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
March 09, 2023
Gainers
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
February 27, 2023
During Monday's session, 56 companies made new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
February 24, 2023
On Friday, 135 companies reached new 52-week lows.
Via
Benzinga
Sonnet Bio Reveals Pharmacokinetic, Pharmacodynamic Data In Early-Stage SON-1010 Trial
January 19, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 15, 2023
On Wednesday, 479 stocks made new 52-week lows.
Via
Benzinga
Sonnet BioTherapeutics to Present Clinical Data from the SB101 Study with SON-1010 at the AACR 2023 Annual Meeting
March 14, 2023
Via
ACCESSWIRE
Stocks That Hit 52-Week Lows On Tuesday
March 14, 2023
Tuesday's morning session saw 84 companies set new 52-week lows.
Via
Benzinga
InvestorNewsBreaks – Sonnet BioTherapeutics Holdings Inc. (NASDAQ: SONN) Releases Pricing of Underwritten Public Offering to Total Estimated $15M
February 14, 2023
Via
Investor Brand Network
Sonnet BioTherapeutics Provides Fiscal Year 2023 First Quarter Business and Earnings Update
February 13, 2023
Via
ACCESSWIRE
Why Sonnet BioTherapeutics (SONN) Shares Are Falling
February 08, 2023
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares are trading lower by 12.97% to $0.94 Wednesday morning after the company announced pricing of a $15 million underwritten public offering....
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 08, 2023
Via
Benzinga
Sonnet BioTherapeutics Announces Pricing of $15.0 Million Underwritten Public Offering
February 08, 2023
Via
ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
February 08, 2023
Our coverage starts today with a look at the biggest pre-market stock movers traders will want to keep an eye on Wednesday!
Via
InvestorPlace
Sonnet BioTherapeutics Announces Successful Completion of Two IND-Enabling Toxicology Studies with SON-1210 in Non-Human Primates
February 01, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Monday's After-Market Session
January 30, 2023
Via
Benzinga
Why FARO Technologies Shares Are Trading Lower By 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 20, 2023
Gainers Helbiz, Inc. (NASDAQ: HLBZ) shares jumped 133.1% to $0.2870. Helbiz recently announced discontinuation of operations in non-profitable markets.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 20, 2023
Via
Benzinga
Why Netflix Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
January 20, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
January 20, 2023
It's the final day of trading this week and we're checking in on the biggest pre-market stock movers for Friday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 19, 2023
Via
Benzinga
Sonnet BioTherapeutics Announces Pharmacokinetic and Pharmacodynamic Data in a Phase 1 Dose-Escalation Trial of SON-1010
January 19, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 09, 2023
Via
Benzinga
Sonnet BioTherapeutics Announces a Collaboration with Roche for the Clinical Evaluation of SON-1010 with atezolizumab in Ovarian Cancer
January 09, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's After-Market Session
December 22, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 20, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022
December 19, 2022
Via
Benzinga
Sonnet BioTherapeutics Provides Fiscal Year 2022 Business and Financial Update
December 15, 2022
Via
ACCESSWIRE
Looking Into Sonnet BioTherapeutics's Recent Short Interest
December 15, 2022
Sonnet BioTherapeutics's (NASDAQ:SONN) short percent of float has risen 11.67% since its last report. The company recently reported that it has 359 thousand shares sold short, which is 5.07% of all...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
November 30, 2022
During Wednesday's session, 107 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
November 22, 2022
During Tuesday's trading, 160 companies set new 52-week lows.
Via
Benzinga
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.